Overview

• After an en banc 7–4 ruling that IEEPA does not authorize sweeping tariffs, the administration filed an expedited certiorari petition seeking a decision by Sept. 10 and potential early‑November arguments, a schedule the challengers support.
• The Federal Circuit’s stay leaves both the fentanyl‑targeted and broad reciprocal tariff programs in effect through Oct. 14 while the Supreme Court considers whether to take the case.
• A coalition of small businesses and a group of states urged the justices to resolve the dispute quickly, warning of severe, non‑survivable harms from price spikes and supply chain disruption.
• U.S. Solicitor General D. John Sauer defends the duties as critical to trade negotiations and investment, while the White House explores other statutory paths such as Sections 232, 301, 122 and 338 to sustain tariff policy if IEEPA fails.
• Policy actions continue on parallel tracks, including a new order implementing a Japan trade deal that sets most tariffs at 15% with sector‑specific treatment and active Section 232 processes like the wind‑turbine inquiry with comments due Sept. 9.